A Multicenter, Open-label Phase 1b Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients with Unresectable or Metastatic BRAFV600-mutant Melanoma

  • Wood, Paul, (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date26/02/2025/02/25

Keywords

  • clinical trial
  • phase 1 study
  • melanoma
  • treatment efficacy